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 34 
Abstract 35 
Background: 36 
Within the European Union (EU), substantial efforts are being made to achieve economic and social 37 
cohesion, and the reduction of health inequalities between EU regions is integral to this process.  This 38 
paper is the first to examine how self-reported conditions and non-communicable diseases (NCDs) vary 39 
spatially between and within countries.   40 
Methods: 41 
Using 2014 European Social Survey (ESS) data from 20 countries, this paper examines how regional 42 
inequalities in self-reported conditions and NCDs vary for men and women in 174 regions (level 1 and 2 43 
Nomenclature of Statistical Territorial Units, ‘NUTS’).  We document absolute and relative inequalities 44 
across Europe in the prevalence of eight conditions: general health, overweight/obesity, mental health, 45 
heart or circulation problems, high blood pressure, back, neck, muscular or joint pain, diabetes and cancer. 46 
Results: 47 
There is considerable inequality in self-reported conditions and NCDs between the regions of Europe, with 48 
rates highest in the regions of continental Europe, some Scandinavian regions and parts of the United 49 
Kingdom and lowest around regions bordering the Alps, in Ireland and France.  However, for mental health 50 
and cancer, rates are highest in regions of Eastern European and lowest in some Nordic regions, Ireland and 51 
isolated regions in continental Europe. There are also widespread and consistent absolute and relative 52 
regional inequalities in all conditions within countries. These are largest in France, Germany and the United 53 
Kingdom, and smallest in Denmark, Sweden and Norway. There were higher inequalities amongst women. 54 
Conclusion: 55 
Using newly available harmonized morbidity data from across Europe, this paper shows that there are 56 
considerable regional inequalities within and between European countries in the distribution of self-57 
reported conditions and NCDs.  58 
 59 
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Survey 66 
1. Introduction 67 
Reducing regional inequalities in Europe, including those associated with health, was a founding aim in the 68 
ECC Treaty of 1957 and reaffirmed in the 2007 Lisbon Treaty which promoted ‘economic, social and 69 
territorial cohesion’ through ever more regional and national harmonisation.  Despite the long standing will 70 
of the European Community and member states to assimilate, inequalities in health have remained high. 71 
Whilst most research to date had focused on understanding inequalities between European countries 1-3, 72 
the work of Shaw et al.4 has shown that using national health data can mask significant within country, 73 
regional variation.  For example, it is well established that there is a North-South health divide in England 5, 74 
6, whilst the East-West divide in Germany has reduced significantly since reunification in respect to both 75 
morbidity and mortality 6-8.  In addition, Richardson et al. 9 demonstrated that there are also significant 76 
regional inequalities in life expectancy across Europe.  77 
 78 
Most previous comparative studies including Richardson et al.9, use data collected by separate national 79 
administrations which may give rise to inconsistencies, particularly concerning data related to morbidity 80 
outcomes which may need to be harmonised.  Our research uses data from the special module on the 81 
social determinants of health of the 2014 European Social Survey (ESS) and documents for the first time 82 
how various self-reported conditions and non-communicable diseases (NCDs) vary at sub-national level 83 
using data from a single source.  Specifically, we investigate the geographical distribution of eight self-84 
reported conditions and NCDs within European countries, and the scale of any regional inequalities within 85 
each country using data from the 2014 ESS. 86 
 87 
2. Methods 88 
Data 89 
This study involved the analysis of the ESS conducted in 2014 (round 7).  The data and documentation on 90 
the survey are provided freely and can be accessed through the ESS website 91 
(http://www.europeansocialsurvey.org).  Data were gathered in 20 countries within Europe.   Whilst most 92 
countries are in the European Union (Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, 93 
Germany, Hungary, Ireland, Lithuania, Netherlands, Poland, Portugal, Slovenia, Spain, Sweden, and the 94 
United Kingdom), others are in the European Free Trade Association (Norway and Switzerland). Random 95 
probability sampling from all private households with persons aged 15 and over was completed between 96 
August 2014 and December 2015.  The average response rate was 51.6% for all countries in the ESS, but 97 
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ranged from 31.4% in Germany to 68.9% in Lithuania.  This paper draws its data from the rotating module 98 
‘Social inequalities in health and their determinants’ described in detail in Eikemo et al. 10. A range of 99 
conditions were asked within the rotating module, including information on general health, limiting 100 
longstanding illness, BMI, mental health and self-reported NCDs.  Eight variables were investigated in this 101 
paper; general health, overweight/obesity, mental health and heart or circulation problems, high blood 102 
pressure, pain, diabetes and cancer (Table 1).  These were chosen as they represent some of the biggest 103 
public health issues which are facing Europe in 21st Century. 104 
 105 
*****TABLE 1 INSERTED HERE***** 106 
 107 
In keeping with previous research 9, regions were determined using the ‘Nomenclature of territorial units 108 
for statistics’ (NUTS) classification.  NUTS is a hierarchical system for dividing up the economic territory of 109 
the EU. Areas are divided into three levels based on population, country administrative divisions or 110 
geographical units; NUTS 1, NUTS 2 or NUTS 3.  NUTS 2 regions (with a typical population of 800,000 to 3 111 
million) were used everywhere other than Germany and the UK which only release their data at the NUTS 1 112 
level (population 3 – 7 million).   113 
 114 
Analysis 115 
Prevalence was calculated for each of the self-reported conditions and NCD variables at sub-national 116 
regions for respondents aged 18 plus1.  Results are presented for all the population, and men and women 117 
separately.  To calculate the regional prevalence of each condition across Europe, all data are weighted 118 
using two weights reported in the ESS: the population size (pweight) weight corrects for different 119 
population sizes between countries, and this was combined with a post-stratification weight (pspweight) 120 
which uses information on age-group, gender, education, and region to reduce the sampling error and 121 
potential non-response bias of the survey.  To facilitate the comparison of regional prevalences across 122 
Europe which may have different population structures, we adjusted the crude prevalences in each area for 123 
five year age groups (up to aged 75 and above which were amalgamated) to a standard population (in 124 
keeping with the reporting of country prevalences by Huijts et al. 11).  The age groups were weighted in 125 
accordance with the European Standard population (ESP) of 2013 12, which is an updated version of the 126 
1976 ESP taking into account an aging European population.  The ESP 2013 is available in spreadsheet 127 
format from ISD Scotland 13.  Within country, regional inequalities did not used the pweight and were not 128 
                                                          
1 Respondents aged 15-17 (representing 3.1% of the ESS sample) were excluded from the analysis to ensure 
maturation of all participants and validity of the Body Mass Index calculation using height and weight alone.   
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age-standardised (as comparison between countries is not required and the pspweight does account for 129 
some regional differences).  Sensitivity analysis using country-level population (obtained from Eurostat) 130 
showed the difference between regional prevalences were typically less than 1% different to those using 131 
the ESS weights alone and therefore not pursued further in subsequent analysis.  132 
 133 
For regional analysis, a sample size of at least 100 respondents per NUTS region was required, and/or a 134 
minimum of 20 cases for each item in the instrument.  The analysed data are represented in map, graphical 135 
and tabular form.  Mapping was completed in ArcMap 10.3 using administrative boundaries downloaded 136 
Eurostat/EuroGeographics.  For visualisation purposes, regions were aggregated into deciles based on cut-137 
offs which include equal numbers of areas in each self-reported condition and NCD.  To document regional 138 
inequalities, countries with fewer than five NUTS 2 (or NUTS 1) regions were excluded from analysis 139 
(following Bambra et al. 14).  This had the consequence that for some more rare conditions (e.g. diabetes), 140 
and particularly when examining prevalences of men and women separately, not all regions and/or 141 
countries sampled are included in the final analysis.   142 
 143 
To calculate country-level regional inequalities, the absolute difference in prevalence between the region 144 
with the lowest and highest incidence of the particular health outcome investigated was also calculated, 145 
and tested for significance.  This ‘risk difference’ was considered alongside the relative risk (or risk ratio) 146 
which calculates the ratio of risk of an event in the two regions.  For all variables, the lowest regional 147 
prevalence was considered the ‘exposed’ group and was divided by the highest regional prevalence (the 148 
‘unexposed’ group).  As such, all risk ratios for this analysis are less than 1. To further quantify the scale of 149 
within-country inequalities, as an example, we calculate for the overweight/obese data the absolute 150 
weighted mean difference from the overall mean.  This shows the difference of health in each region 151 
(weighted) from a reference point.  Whilst a variety of measures to quantify subnational regional 152 
inequalities are available, the mean difference from the mean was chosen as it can be easily communicated 153 
to non-technical audiences 15.  As the ESS data were not purposively sampled at the regional level, we used 154 
population data for females and males respectively direct from Eurostat (table: demo_r_d22jan) for only 155 
those regions with sufficient data.  The national coverage was calculated using only data for these regions 156 
in addition.  Higher numerical values indicate more widespread inequalities. 157 
 158 
*****FIGURE 1 INSERTED HERE***** 159 
 160 
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3. Results 161 
Regional prevalence of self-reported conditions and NCDs across Europe 162 
Figure 1 shows regional variation in self-reported conditions and NCDs for the total population in 20 163 
countries included in the ESS (the raw data showing prevalences at NUTS 1/2 level is available from the 164 
corresponding author on request).  Overall it is clear not only that all conditions affect substantial 165 
proportions of respondents, but we also see considerable variation in prevalences both across Europe and 166 
within individual countries.  Direct comparison between all regions sampled in the ESS is however not 167 
possible as some data had to be excluded due to low sampling counts (illustrated using cross hatching on 168 
maps presented).  Poor general health is highest in Hungary and in some eastern and southern European 169 
countries and lowest in Switzerland, Austria, and Ireland.  For example in Észak-Magyarország (Hungary), 170 
the rate of poor general health is 19.24% compared to ca. 1% in Espace Mittelland in Switzerland.  The 171 
prevalence of overweight/obesity is more spatially heterogeneous, with rates highest in parts of the United 172 
Kingdom, Scandinavia and central Germany and lowest in urban areas of Germany and Switzerland (e.g. 173 
Berlin, Zurich), Poland and central and north-west France.  The prevalence of depressive symptoms is 174 
highest in parts of Hungary, Germany, Czech Republic and parts of Spain and Portugal where rates can 175 
reach > 30% and lowest in parts of Scandinavia (e.g. Agder and Rogaland in Norway 3.99%) and Switzerland.  176 
Heart and circulation problems are also spatially variable within regions of the EU with a range of over 17% 177 
between the least and most affected regions.  For example in Wales (UK), only 3.37% of respondents 178 
reported problems during the past 12 months compared to the Thüringen region of Germany which has a 179 
rate of 21.15%.  Problems associated with high blood pressure also show considerable regional variation 180 
across Europe ranging from less than 5% in Salzburg in Austria to around 40% in the Thüringen and the 181 
Sachsen-Anhalt areas of Germany.  Rates of back or neck/ muscular or joint pain in the hand/arm or 182 
foot/leg however show the greatest range amongst the eight self-reported conditions reported here.  The 183 
lowest rates are reported in parts of Hungary, the Czech Republic and Poland where typically less than 30% 184 
of the total population aged over 18 reports some kind of pain in the past 12 months compared to regions 185 
of France, Belgium and Sweden for which the percentage is considerably higher at around 80% of survey 186 
respondents.  The prevalence of diabetes also displays a distinct patterning with the worst affected regions 187 
centring on northern Germany, Portugal, northern Finland, and parts of the United Kingdom with rates 188 
lowest in southern Germany and Switzerland.  Finally, those survey respondents reporting cancer also 189 
varies across the regions of Europe: Poland, Spain and some Scandinavian regions report the lowest 190 
prevalences with rates highest in Hungary and Switzerland.   191 
 192 
Although there are considerable regional differences amongst the eight self-reported conditions and NCDs 193 
examined here, some broad trends are evident in the maps presented in Figure 1.  For self-rated health, 194 
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overweight and obesity, high blood pressure, pain (and a lesser extent diabetes), the prevalence of the 195 
particular condition of interest is highest in continental Europe (centred on North/East Germany), high also 196 
in some Scandinavian regions and parts of the United Kingdom and lowest around countries bordering the 197 
Alps, Ireland and some regions in France.  No clear east-west gradient is evident, with prevalences showing 198 
considerable geographic variability between and within individual countries although for the maps of 199 
mental health and cancer, rates are highest in regions of Eastern European countries and lowest in some 200 
Nordic regions, Ireland and isolated regions in continental Europe.  201 
 202 
*****FIGURE 2 INSERTED HERE***** 203 
 204 
Within country regional inequalities in self-reported conditions and NCDs 205 
Bar graphs of within-country absolute regional inequalities (high to low) for the total population in the eight 206 
conditions examined in this paper are detailed in Figure 2 (and full tables of all country-level regional 207 
inequalities for the total population, and men and women reported separately are displayed online in 208 
Additional file 1).  For most of the conditions, the highest regional levels of inequality are found in France, 209 
Germany, the United Kingdom, Hungary and Austria.  For example, the difference between the highest 210 
(Thüringen) and lowest (Rheinland-Pfalz) regions with a CES-D 8 depression score is 23.76%.  France also 211 
displays persistent absolute inequality in many of the variables, for example there was a difference of 212 
11.95% of respondents who have or have had heart or circulation problems between regions.  In the Midi-213 
Pyrenees region, just 5.83% of respondents claimed to have heart or circulation problems, compared to 214 
Aquitaine which had 17.78%.  In comparison, Sweden, Denmark, Switzerland and Norway showed some of 215 
the smallest regional inequalities in self-reported conditions. There was only a 6.27% difference between 216 
Roskilde County and Frederiksborg County (Denmark) in pain.  Furthermore, the eight valid regions of 217 
Sweden had a difference in overweight/obese status of just 12.03%, compared to Germany where this 218 
figure more than doubles (28.76%).  219 
 220 
*****TABLE 2 INSERTED HERE***** 221 
 222 
For some of the self-reported conditions it was possible to use the data from the ESS to investigate how 223 
regional inequalities vary between men and women.  Unfortunately for many of the variables, the low 224 
sampling counts meant this was only meaningful for some of the most prevalent conditions (e.g. 225 
overweight/obese status).  However, by combining the overweight/obese category we mask the difference 226 
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in health by different BMI categories16.  Nevertheless, Figure 3 shows higher inequalities amongst women 227 
as reported elsewhere 17, and also significant regional variability between the sexes.  For example women in 228 
Norway showed the highest levels of inequalities in overweight/obesity amongst countries in the ESS, with 229 
a difference of 36.75% between the most and least obese regions.  In comparison, the men of Norway 230 
displayed the lowest levels of overweight/obesity with a regional difference of just 6.25%.  The situation 231 
was reversed for United Kingdom where men had higher absolute and relative inequalities compared to 232 
women. 233 
 234 
*****FIGURE 3 INSERTED HERE***** 235 
 236 
The relative risk between the regions reporting the lowest and highest values for each of the self-reported 237 
conditions is shown in Table 2.  Relative risks closest to 1 indicate little difference between regions, with 238 
those values closest to 0 indicating countries with the greatest inequalities.  For example, in the United 239 
Kingdom, the region with the least prevalence of overweight/obesity (Greater London) had a risk of 0.634 240 
of having a BMI greater than 25 compared to the region reporting the highest prevalence (North East) – or 241 
37% less chance.  The significance of the within-country regional inequalities using risk difference (where p 242 
< 0.05) is illustrated for each self-reported condition using an asterisk.  From the table it is evident that 243 
regional inequalities are widespread and significant in France, Germany, the United Kingdom (and to a 244 
lesser extent in Spain, Poland and Hungary).  Relative regional inequalities are not significant in Denmark 245 
and to a lesser extent Sweden and Norway.  To illustrate the scale of inequalities across all regions, the 246 
weighted mean difference from the mean has been applied to the overweight/obese data (Table 3).  The 247 
countries are ordered by the greatest absolute difference (low to high).  It is evident that those countries 248 
with the greatest absolute difference generally also have high weighted mean difference calculations 249 
suggesting that inequalities are persistent across all regions.  For example, women in Norway and 250 
Switzerland have the highest and lowest absolute inequalities between regions respectively and also the 251 
greatest (and least) inequalities across all regions.  However women in Spain and men in Hungary for 252 
example, have a much higher weighted mean difference compared to their high to low absolute difference 253 
indicating widespread regional differences in the prevalence of overweight/obesity.   254 
 255 
 256 
4. Discussion 257 
9 
 
The results presented here present a first examination of European regional inequalities in the prevalence 258 
of a range of self-reported conditions and NCDs from the new special rotating module on social inequalities 259 
in health developed for the 7th wave of the ESS (2014). Overall, we found considerable regional differences 260 
in prevalences amongst the eight self-reported conditions investigated within the European area.  Most 261 
importantly, we found country-level regional inequalities are most noticeably smaller in some countries 262 
(e.g. Denmark) and larger and statistically significant in others (e.g. Germany, France and the United 263 
Kingdom).  The study of regional geographic variations in health outcomes is still in its infancy, and this 264 
paper provides a unique overview of the extent and scale of regional variability between and within 20 265 
countries in the European region.  The significant regional variability illustrated in this paper underlines the 266 
importance of examining smaller geographic units when documenting health outcomes, something which is 267 
largely ignored in most comparative studies which typically report country-level health outcomes.   268 
 269 
Our findings are largely in keeping with previous single country studies of regional inequalities in health. For 270 
example, research conducted in Germany, Finland and the UK has highlighted how distinct regional 271 
differences in diabetes prevalence are evident 18-20, potentially attributable to underlying structural 272 
deprivation operating at the contextual regional level, as well as compositional variables related to the 273 
socio-economic status or ethnic composition of the population living in these areas 18, 21. However, there 274 
are some differences in the results described here with more detailed analysis conducted within individual 275 
countries.  For example, the prevalence of depressive symptoms was 3.99% in Agder and Rogaland 276 
however research from the Norwegian Institute of Public Health 22 has highlighted Agder has a higher 277 
incidence of psychiatric symptoms and disorders than the rest of Norway, particular in younger age groups.  278 
Whilst this discrepancy could be associated with the self-reporting in the ESS compared to clinical 279 
diagnosis, is maybe a function of the sampling design, particularly the small number of cases in some 280 
regions.  Also, for some countries (Denmark, Germany, Poland, Portugal, Slovenia, Spain, Sweden and the 281 
United Kingdom) statistical inference is not possible at the regional level (see ‘ESS7 – 2014 Documentation 282 
Report’ for further details 23).  As such, caution should exercised when interpreting results, and comparison 283 
to more comprehensive national studies should be undertaken alongside the analysis regional level 284 
described here.  The ESS was never sampled for analysis at the regional level, so it may be possible that the 285 
respondents are not representative of the population at sub-national level. However, for all analyses the 286 
pspweight was used which incorporated information on age-group, gender, education as well as region to 287 
ensure these effects are minimised.  However, the heterogeneity of self-reported health outcomes in small 288 
areas of Europe found in our study raises the possibility that regional-level health inequalities are reflecting 289 
underlying spatial differences in socioeconomic conditions.  Therefore further analysis should focus on 290 
trying to explain these variations using modelling techniques incorporating compositional and contextual 291 
variables to understand the drivers of regional differences in self-reported conditions and NCDs.   292 
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 293 
This paper provides a unique insight into the extent of regional inequalities in self-reported conditions and 294 
NCDs over most of Europe by using a comparable dataset for 20 European countries.  However, there are 295 
some limitations associated with the design and analysis of the data which may have methodological 296 
implications.  Firstly, the low sampling counts for some of the self-reported conditions is a limitation of this 297 
study, in part due the pattern of sampling within the ESS which was not designed for complete and 298 
representative regional analysis.  Consequently, for some of the self-reported conditions which are less 299 
common (such as diabetes or cancer), there are many regions for which comparison was not possible.  For 300 
the same reason, documenting gender differences in many of the health outcomes is problematic except 301 
for the most common health outcomes (e.g. overweight/obesity), for which there are sufficient data.  302 
Secondly, whilst the focus of analysis was NUTS 2, for the United Kingdom and Germany only data at NUTS 303 
1 was available.  The unit of analysis (and the number of country subgroups) would change the prevalence 304 
of some of the regional analysis displayed here, particularly considering within-country regional 305 
inequalities.  In the same way, even amongst the NUTS 2 regions, there are significant population 306 
differences in regions which would undoubtedly have implications for the results presented here.  For 307 
example, the Luxembourg Province in Belgium has a population of 278,651, compared to La Réunion in 308 
France which has 839,334 people in 201424.  The low (and varying) response rate may also influence the 309 
results presented here.  Whilst weighting is used to adjust for this potential bias, it is unclear without 310 
detailed knowledge of geographical distribution of health outcomes at country level, whether these are 311 
sufficient.  Furthermore, whilst calculating the within-country regional differences, only the lowest and 312 
highest regional values for calculating risk difference and risk ratio are used across all health outcomes.  313 
This masks the scale and depth of inequality in any one country.  Our analysis therefore measures the 314 
health ‘gap’ between regions.  However our preliminary investigation using the absolute weighted mean 315 
difference suggests that for overweight/obesity the pairwise measure of high to low absolute difference is a 316 
reasonable approximation of the scale and depth of regional inequality across a country.  Future work could 317 
focus more on the gradient, examining the possible role of deprivation (using for example the Slope Index 318 
of Inequality and Relative Index of Inequality) in the patterns we have found.  Finally, the ESS uses self-319 
reported data on NCDs, rather than clinical diagnosis. 320 
 321 
5. Conclusion 322 
This paper has examined how the prevalence of self-reported conditions and NCDs varies spatially between 323 
and within countries using a unique new harmonised data set: the European Social Survey special module 324 
on health inequalities in Europe from 2014. We have found that there is considerable inequality in 325 
conditions between the regions of Europe, with rates highest in the regions of continental Europe, some 326 
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Scandinavian regions and parts of the United Kingdom and lowest around regions bordering the Alps, in 327 
Ireland and France.  However, for mental health and cancer, rates are highest in regions of Eastern 328 
European and lowest in some Nordic regions, Ireland and isolated regions in continental Europe. There are 329 
also widespread and consistent absolute and relative regional inequalities in all self-reported conditions 330 
and NCDs within countries. These are largest in France, Germany and the United Kingdom, and smallest in 331 
Denmark, Sweden and Norway. There were higher inequalities amongst women. Future research should 332 
explore the underlying reasons for these inequalities.  These large relative and absolute differences across 333 
Europe imply that a more concerted effort at both the national and EU level is needed to tackle regional 334 
inequalities.  Successfully evaluated interventions shown to reduce regional health inequalities should be 335 
adopted across Europe (perhaps using EU structural funds), coordinated by policy makers in order to plan 336 
and deliver successful public health strategies to harmonise regions and finally realise the aims of the ECC 337 
Treaty from 1957. 338 
 339 
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Table 1 Self-reported conditions and NCD variables taken from the ESS rotating module on ‘Social 348 
inequalities in health and their determinants’. 349 
Variable  Variable description and/or ESS question ESS7 
Question 
No. 
Self-rated health (poor 
health) 
How is your health in general? Would you say it is: 
 Very good 
 Good 
 Fair 
 Bad 
 Very bad 
Self-rated health graded poor/very poor (as oppose to fair/good/very good) 
C7 
Overweight/ obesity Self-reported height and weight converted to BMI.  Overweight/ obese (BMI > 25) as 
opposed to underweight/ normal (BMI < 25). 
E11 
E12 
Mental health Depression measured using the eight-item version of the Centre for Epidemiological 
Studies Depression Scale (CES-D8)25 dichotomised to above or below depression cut-off 
value (10 out of 24), as outlined in Huijts et al. 11 . 
E20-27 
Heart or circulation 
problems 
Which of the health problems [detailed below] have you had or experienced in the last 
12 months? 
 Heart or circulation problems 
E28 
High blood pressure Which of the health problems [detailed below] have you had or experienced in the last 
12 months? 
 High blood pressure 
E28 
Back or neck 
pain/muscular or joint 
pain in hand/arm or 
foot/leg 
Which of the health problems [detailed below] have you had or experienced in the last 
12 months? 
 Back or neck pain 
 Muscular or joint pain in hand or arm 
 Muscular or joint pain in foot or leg 
E28 
Diabetes Which of the health problems [detailed below] have you had or experienced in the last 
12 months? 
 Diabetes 
E28 
Cancer Do you have or have you ever had: 
 cancer affecting any part of the body 
 leukemia 
 malignant tumor 
 malignant lymphoma  
 melanoma, carcinoma, or other skin cancer  
E30 
 350 
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Table 2 Within country regional inequalities.  Relative risk (high to low relative ratio) is shown between regions for the total population for each self-reported 
condition and NCD (confidence intervals at 95% shown in brackets).  Significance using risk difference is signified with an asterisk (where p < 0.05). 
Country 
Self-rated poor 
health 
Overweight/ 
obesity Depression 
Heart or circulation 
problems High blood pressure Pain Diabetes Cancer 
Austria 
0.311 
(0.032 – 3.059) 
0.659 
(0.421 – 1.030) 
0.629 
(0.299 – 1.266) 
0.341 
(0.070 – 1.655) 
0.198 * 
(0.044 – 0.890) 
0.528 * 
(0.294 – 0.950) 
0.284 
(0.020 – 3.966) 
0.361 
(0.099 – 1.310) 
Belgium 
0.467 
(0.133 – 1.648) 
0.685 * 
(0.492 – 0.955) 
0.295 * 
(0.115 – 0.755) 
0.368 
(0.123 – 1.101) 
0.346 * 
(0.142 – 0.842) 
0.695 * 
(0.540 – 0.893) 
0.331 
(0.083 – 1.321) 
0.513 
(0.192 – 1.367) 
Czech Republic 
0.491 
(0.161 – 1.495) 
0.680 * 
(0.529 – 0.875) 
0.505 * 
(0.272 – 0.937) 
0.329 
(0.100 – 1.079) 
0.539 
(0.274 – 1.060) 
0.448 * 
(0.293 – 0.686) 
0.392 
(0.097 – 1.584) - 
Denmark 
0.653 
(0.214 – 1.986) 
0.857 
(0.562 – 1.306) 
0.613 
(0.270 – 1.393) 
0.559 
(0.215 – 1.451) 
0.646 
0.358 – 1.163) 
0.910 
(0.737 – 1.122) 
0.625 
(0.125 – 3.117) 
0.517 
(0.238 – 1.119) 
France 
0.528 * 
(0.323 – 0.863) 
0.708 * 
(0.609 – 0.823) 
0.519 * 
(0.319 – 0.844) 
0.328 * 
(0.200 – 0.538) 
0.501 * 
(0.341 – 0.734) 
0.576 * 
(0.501 – 0.661) 
0.466 * 
(0.255 – 0.852) 
0.636 * 
(0.427 – 0.949) 
Germany 
0.413 * 
0.243 – 0.701) 
0.596 * 
(0.496 – 0.715) 
0.198 * 
0.119 – 0.331) 
0.520 * 
(0.368 – 0.736) 
0.517 * 
(0.413 – 0.647) 
0.757 * 
(0.668 – 0.858) 
0.159 * 
(0.094 – 0.269) 
0.616 * 
(0.449 – 0.845) 
Hungary 
0.606 
(0.272 – 1.351) 
0.728 * 
0.583 – 0.910) 
0.442 * 
(0.299 – 0.652) 
0.190 * 
(0.053 – 0.685) 
0.127 * 
(0.040 – 0.397) 
0.338 * 
(0.188 – 0.607) 
0.306 
(0.068 - 1.377) 
0.216 * 
(0.088 – 0.531) 
Netherlands 
0.478 
(0.182 – 1.254) 
0.588 * 
(0.364 – 0.951) 
0.538 
(0.214 – 1.353) 
0.464 * 
(0.220 – 0.976) 
0.713 
(0.408 – 1.247) 
0.473 * 
(0.261 – 0.859) 
0.511 
(0.143 – 1.822) 
0.616 
(0.270 – 1.405) 
Norway 
0.392 
(0.095 – 1.609) 
0.639 * 
(0.453 – 0.903) 
0.339 
0.066 – 1.734) 
0.585 
(0.139 – 2.465) 
0.524 
(0.220 – 1.244) 
0.771 
(0.576 – 1.031) 
0.226 
(0.018 – 2.880) 
0.456 
(0.139 – 1.501) 
Poland 
0.562 * 
(0.336 – 0.940) 
0.601 * 
(0.490 – 0.737) 
0.652 * 
0.456 – 0.934) 
0.820 
(0.561 – 1.199) 
0.468 * 
(0.313 – 0.700) 
0.454 * 
(0.348 – 0.593) 
0.649 
0.307 – 1.372) 
0.392 * 
(0.205 – 0.749) 
Portugal - 
0.734 
(0.556 – 0.969) - - - 
0.689 *  
(0.467 – 1.018) - - 
Spain 
0.590 * 
(0.357 – 0.978) 
0.815 * 
(0.637 – 1.041) 
0.655 * 
(0.440 – 0.975) 
0.464 * 
(0.247 – 0.872) 
0.652 * 
(0.436 – 0.974) 
0.628 * 
(0.494 – 0.798) 
0.565 
(0.263 – 1.213) 
0.647 
(0.299 – 1.399) 
Sweden 
0.373 
(0.089 – 1.559) 
0.799 
(0.615 – 1.038) 
0.574 
(0.218 – 1.507) 
0.516 
(0.224 – 1.190) 
0.663 
(0.340 – 1.293) 
0.712 * 
(0.571 – 0.887) 
0.381 
(0.096 – 1.508) 
0.411 * 
(0.178 – 0.946) 
Switzerland 
0.165 * 
(0.028 – 0.985) 
0.689 
(0.453 – 1.048) 
0.554 
0.210 – 1.463) 
0.499 
(0.172 – 1.447) 
0.818 
(0.368 – 1.819) 
0.731 * 
(0.565 – 0.947) 
0 
(0 - ∞) 
0.560 
(0.294 – 1.066) 
United Kingdom 
0.233 * 
(0.119 – 0.454) 
0.634 * 
(0.563 – 0.714) 
0.403 * 
(0.286 – 0.569) 
0.329 * 
(0.198 – 0.549) 
0.572 * 
(0.440 – 0.744) 
0.705 * 
(0.599 – 0.831) 
0.362 * 
(0.184 – 0.712) 
0.432 * 
(0.267 – 0.701) 
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Table 3 Absolute weighted mean difference from the overall mean calculated for the percentage of 
overweight/obesity for females and males separately.  Countries weighted by population (from table 
‘demo_r_d2jan’ taken from Eurostat).  Countries are ordered by their high to low absolute difference 
(taken from Figure 2). 
 FEMALES  MALES 
Country Weighted 
mean 
difference 
Weighted 
mean 
difference 
(order) 
 Country Weighted 
mean 
difference 
Weighted 
mean 
difference  
(order) 
1 Norway 9.579 1  1 United Kingdom 6.648 2 
2 Czech Republic 7.416 3  2 Spain 5.153 5 
3 France 6.531 4  3 Czech Republic 7.729 1 
4 Germany 5.919 5  4 Austria 3.162 12 
5 United Kingdom 5.092 8  5 France 6.375 3 
6 Hungary 8.056 2  6 Germany 3.997 11 
7 Netherlands 3.019 13  7 Poland 4.527 6 
8 Belgium 3.846 11  8 Sweden 4.096 10 
9 Poland 3.877 10  9 Belgium 4.152 9 
10 Portugal 4.047 9  10 Hungary 5.643 4 
11 Austria 5.315 7  11 Switzerland 4.492 7 
12 Spain 5.587 6  12 Netherlands 4.217 8 
13 Sweden 3.725 12  13 Denmark 2.283 13 
14 Switzerland 1.809 14  14 Norway 1.938 14 
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Figure 1 Regional prevalence’s in self-reported conditions and NCDs for the total population at NUTS 2 
(except for Germany and the UK where data are only available at NUTS 1).   Administrative boundaries from 
EuroGeographics. 
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Figure 2. Regional inequalities in self-reported conditions and NCDs.  The high to low absolute difference (in 
percentage points) represents the within-country difference in regional prevalence of each of the self-
reported conditions.  The asterisks represents countries which have a significant risk difference (where p = 
< 0.05).   
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Figure 3 Country-level regional inequalities in overweight/obesity status in women (left) and men (right).  
The high to low absolute difference (in percentage points) represents the within-country difference in 
regional prevalence in the prevalence of overweight/obese status.  The asterisks represents countries 
which have a significant risk difference (where p = < 0.05).   
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